The Manufacturers Life Insurance Company Purchases New Shares in The Cooper Companies, Inc. $COO

The Manufacturers Life Insurance Company purchased a new position in The Cooper Companies, Inc. (NASDAQ:COO) during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The firm purchased 964,007 shares of the medical device company’s stock, valued at approximately $69,129,000. The Manufacturers Life Insurance Company owned approximately 0.49% of Cooper Companies at the end of the most recent quarter.

A number of other hedge funds also recently bought and sold shares of the company. Heartland Advisors Inc. purchased a new position in Cooper Companies during the 4th quarter worth approximately $15,348,000. Mitsubishi UFJ Asset Management Co. Ltd. grew its holdings in shares of Cooper Companies by 6.0% during the fourth quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 421,948 shares of the medical device company’s stock valued at $34,224,000 after buying an additional 23,896 shares in the last quarter. Tocqueville Asset Management L.P. acquired a new stake in shares of Cooper Companies during the second quarter worth approximately $1,502,000. Swedbank AB lifted its position in Cooper Companies by 18.8% in the 4th quarter. Swedbank AB now owns 1,074,029 shares of the medical device company’s stock worth $88,027,000 after buying an additional 170,000 shares in the last quarter. Finally, Capital International Inc. CA increased its stake in shares of Cooper Companies by 22.9% in the fourth quarter. Capital International Inc. CA now owns 118,210 shares of the medical device company’s stock worth $9,688,000 after acquiring an additional 22,054 shares during the last quarter. 24.39% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of brokerages have recently commented on COO. Citigroup reaffirmed a “neutral” rating and issued a $80.00 target price (up from $76.00) on shares of Cooper Companies in a report on Thursday, August 13th. Needham & Company LLC cut their price objective on shares of Cooper Companies from $101.00 to $86.00 and set a “buy” rating for the company in a research report on Friday, June 5th. The Goldman Sachs Group set a $61.00 price target on shares of Cooper Companies in a research note on Wednesday, May 27th. Stifel Nicolaus reduced their price target on Cooper Companies from $95.00 to $85.00 and set a “buy” rating for the company in a report on Friday, June 5th. Finally, JPMorgan Chase & Co. reduced their target price on Cooper Companies from $80.00 to $71.00 and set a “neutral” rating for the company in a report on Friday, June 5th. One analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, six have issued a Hold rating and three have issued a Sell rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $81.64.

Cooper Companies Stock Performance

Shares of COO opened at $73.04 on Wednesday. The company has a 50-day moving average of $72.20 and a two-hundred day moving average of $71.01. The stock has a market cap of $14.24 billion, a P/E ratio of 61.90, a PEG ratio of 1.98 and a beta of 0.83. The Cooper Companies, Inc. has a 12-month low of $58.89 and a 12-month high of $89.83. The company has a current ratio of 1.27, a quick ratio of 0.78 and a debt-to-equity ratio of 0.23.

Cooper Companies (NASDAQ:COO) last issued its quarterly earnings data on Thursday, June 4th. The medical device company reported $1.21 earnings per share for the quarter, topping analysts’ consensus estimates of $1.10 by $0.11. The business had revenue of $1.08 billion during the quarter, compared to analysts’ expectations of $1.05 billion. Cooper Companies had a net margin of 5.57% and a return on equity of 10.88%. The company’s revenue was up 7.9% on a year-over-year basis. During the same period last year, the company posted $0.96 EPS. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. As a group, research analysts predict that The Cooper Companies, Inc. will post 4.63 EPS for the current fiscal year.

Cooper Companies News Summary

Here are the key news stories impacting Cooper Companies this week:

• Positive Sentiment: Traders purchased 4,056 call options on COO, roughly 411% above the typical daily volume of 794 contracts. This points to increased speculative bullish interest, although options activity alone does not guarantee a sustained stock advance.
• Neutral Sentiment: The latest short-interest report lists zero shares sold short and a 0.0-day short-interest ratio, but it also describes the change as “NaN” from a prior total of zero. The figures appear inconsistent and provide little useful information about investor positioning. Short Interest Report
• Negative Sentiment: COO’s valuation remains demanding, with a reported P/E ratio near 62. That can make the shares more sensitive to profit-taking or a lack of fresh positive catalysts, even though the company recently exceeded quarterly earnings and revenue expectations and reported year-over-year revenue growth.

Cooper Companies Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.